Antimicrobial Activity of Ceftazidime-Avibactam (CAZ-AVI) among the Carbapenemase-Producing Gram-negative Rods Isolated from Clinical Samples
Introduction: Treating Gram-negative bacteria that produce extendedspectrum beta-lactamases (ESBLs), AmpC Beta lactamases, and carbapenemases is a significant clinical concern worldwide. To address this concern, Ceftazidime-Avibactam has been approved by the United States Food and Drug Administr...
Saved in:
| Main Authors: | Ravi Kumar Sharma1, Monica Monica1, Arindam Chakraborty1* |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pasteur Institute of Iran
2023-06-01
|
| Series: | Journal of Medical Microbiology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://jommid.pasteur.ac.ir/article-1-508-en.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ICU environment as a reservoir of KPC-ST307-Klebsiella pneumoniae high-risk clone resistant to ceftazidime-avibactam
by: Marta Hernández-García, et al.
Published: (2025-08-01) -
Reporting antimicrobial susceptibility and detection of carbapenemase production in single and double carbapenemase-producing Gram-negative clinical isolates: a nationwide proficiency study
by: Felipe Fernández-Cuenca, et al.
Published: (2025-06-01) -
The Use of Ceftazidime–Avibactam in a Pediatric Intensive Care Unit—An Observational Prospective Study
by: Raquel García Romero, et al.
Published: (2024-11-01) -
Identification and characterisation of colistin-resistant Acinetobacter colistiniresistens co-producing IMP-1 and OXA-58 carbapenemases
by: Satoshi Nishida, et al.
Published: (2024-12-01) -
The Prevalence of Metallo-β-lactamase (MBL) in Gram Negative Bacilli and their Antimicrobial Susceptibility Pattern at Tertiary Care hospital, Vadodara
by: Nisarg Trivedi, et al.
Published: (2025-04-01)